Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Cert. of designation
Quarterly results
Auditor change
Acq. announced
Director departure
DermTech, Inc. (CNAC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2019 8-K Acquisition/merger/asset purchase announced
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : August 7, 2019 Constellation Alpha Capital Corp. British Virgin Islands 001-38118 N/A Emerald View, Suite 400, 2054 Vista Parkway West Palm Beach, FL 33411 404-9034 Not Applicable Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: ☒ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ☐ Pre-commencement communica..."
05/29/2019 8-K Investor presentation, Acquisition/merger/asset purchase announced
Docs: "Merger Agreement, by and between CNAC, Merger Sub and DermTech",
"Form of Subscription Agreement, by and between CNAC and certain Subscribers",
"Deferred Underwriting Fee Assignment Agreement, by and between CNAC, DermTech and Cowen",
"Forfeiture Agreement, by and between the Sponsor, CNAC and DermTech",
"Form of Stockholder Support Agreement, by and among CNAC and the stockholders of DermTech party thereto",
"Constellation Alpha Capital Corp. to Merge with DermTech, Inc., a leading innovator of genomics for dermatology and non-invasive skin cancer diagnosis and La Jolla, CA. May 29, 2019 - Constellation Alpha Capital Corp. , a special purpose acquisition company, announced that it has executed a definitive agreement to merge with DermTech, Inc. , a molecular genomics company, with an initial focus on skin cancer, that develops and markets novel non-invasive diagnostic tests. About DermTech, Inc.",
"Form of Investor Presentation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy